Humanwell PuraCap Pharmaceuticals (Wuhan) Co., Ltd. (hereinafter referred to as “the Company”) has been cultivating the US pharmaceutical market for many years, and has maintained favorable strategic cooperation with CVS and Wal-Mart (major US drugstore chain retail enterprises), Reckitt Benckiser and PLD (international brand operators), etc. Moreover, the Company actively explores markets outside the United States, such as Peru, Chile and Ecuador (located in Central and South America), Thailand and Vietnam (located in Southeast Asia), and countries along the Belt and Road. Currently, it has established healthy cooperative relations with many well-known foreign trade companies in China to jointly develop the international market.
1. Provide products that satisfy quality standards of US Food and Drug Administration (FDA);
2. Abundant product lines: including over the counter (OTC) and prescription drugs;
3. Competitive price and stable supply capacity.